With a following wind JW looks to go public
The Juno/Wuxi venture will soon become one of just a few Chinese cell therapy players with a stock exchange listing.
Venture investors: biotech's preppers?
A handful of huge financings helped start-ups raise a record $5.4bn in the second quarter as investors brace for tougher times.
